Science Market Update

Fred Hutch: $7M in Research Funding for Study of Second Primary Breast Cancer

Posted by Rebecca Partridge on Wed, Aug 16, 2017

Between 3 to 20 percent of women with breast cancer will develop another primary cancer tumor in the opposite breast within ten years of the first diagnosis. Though previous studies have identified some environmental, genetic, and treatment-related risk factors for contralateral breast cancer, scientists still don’t fully understand what causes these second primary cancers.

Read More

Tags: Fred Hutch, Fred Hutchinson Cancer Research Center, Cancer Center, cancer research funding, 2017 research funding, BioResearch Product Faire, Research Funding, Biotechnology trade show, laboratory suppliers, breast cancer, Hutch

Fred Hutch Receives $6.4M in Research Funding to Improve Heart Health of Cancer Survivors

Posted by Rebecca Partridge on Tue, Jun 27, 2017

 In March, the National Cancer Institute (NCI) approved a $3.7 million, five-year grant to extend Dr. Eric Chow’s research into improving treatment of cardiovascular risk factors in childhood cancer survivors. Dr. Chow is a clinical researcher, epidemiologist, and pediatric oncologist at Fred Hutchinson Cancer Research Center in Seattle, Washington. This is one of two research grants to be awarded to Dr. Chow by the National Cancer Institute. The NCI also chose to extend Dr. Chow’s study of the long-term efficacy of a medication meant to minimize or prevent heart injury in pediatric patients going through chemotherapy. This $2.7 million in research funding will allow for four more years of studies regarding the use of dexrazoxane in pediatric cancer patients. 

Read More

Tags: Fred Hutch, Fred Hutchinson Cancer Research Center, Cancer Center, Pediatric Cancer Research, cancer research funding, 2017 research funding, BioResearch Product Faire, Research Funding, Biotechnology trade show, laboratory suppliers, general lab supply, Hutch

University of Minnesota Receives $8.2M in New Funding for Cancer Research

Posted by Emily Olson on Wed, Nov 09, 2016

The University of Minnesota has been awarded a five-year $8.2 million grant from the The National Cancer Institute (NCI) to develop a cell migration simulator that will predict how cancer cells move throughout the body.

Read More

Tags: University of Minnesota Twin Cities, Minnesota, University of Minnesota, UMinn, MN, Midwest Region, cancer research, cancer research funding, new research grant, Research Funding

USC Receives $12M to Study Genetic Variants in Breast Cancer

Posted by Laura Braden on Thu, Aug 11, 2016

According to the American Cancer Society, nearly 1 in 8 women will develop breast cancer in their lives, making it the second most common cancer for American women. However, breast cancer does not affect all women equally. Past studies have shown that women of African descent with breast cancer die at a higher rate than white women. Researchers at the University of Southern California Keck School of Medicine have received a grant of $12 million from the National Cancer Institute (NCI) to study the disparities in breast cancer in women.

Read More

Tags: 2016, USC, University of Southern California, CA, California, breast cancer research, cancer research funding, BioResearch Product Faire Event, NIH grant

UCLA Receives $7.6M for Research on Tumor Eradicating Stem Cells

Posted by Katheryn Rein on Wed, Apr 06, 2016

A UCLA cancer research team has recently received a $7.6 million grant from the California Institute for Regenerative Medicine. This award will support research into genetically engineered white blood cells which can selectively target and kill tumor cells, while simultaneously activating other immune cells to do the same.

Read More

Tags: CA, University of California Los Angeles, Stem Cells, Los Angeles, genetic engineering, UCLA, Biotechnology Vendor Showcase, new funding, cancer research funding, tumor cells

Researchers at Fred Hutch Identify Cancer-Spreading Molecule

Posted by Robert Larkin on Fri, Jun 05, 2015

Pancreatic cancer is one of the most rapidly spreading cancers known to man, which translates to seriously staggering death rates. According to the American Cancer Society, for all stages of pancreatic cancer combined, the one-year relative survival rate is 20%, and the five-year rate is 6%, in part because more than 80% of patient tumors have spread beyond the pancreas by the time of diagnosis. In most cases, the cancer has already spread to the point where surgical removal is impossible. (Image: Test Molecule; Los Angeles Mission College)

Read More

Tags: Fred Hutchinson Cancer Research Center, Washington, cancer research, Cancer, 2015, BioResearch Product Faire Event, Seattle, NIH funding, Northwest Region, Hutch, cancer research funding

Harvard Receives $1.1M in NIH Funds for Cancer Therapy Research

Posted by Robert Larkin on Mon, May 11, 2015

Scientists at Harvard Medical have made a recent breakthrough in cancer therapy research with the help of three separate grants from the National Institutes of Health, totaling over $1,153,000.

Read More

Tags: Harvard University, breast cancer research, cancer research, Massachusetts, Longwood Medical Center, 2015, Boston, BioResearch Product Faire Event, Harvard Medical, MA, Harvard, NIH funding, research grants, breast cancer funding, NIH grants, cancer research funding, best lab supply tradeshows, best science tradeshows

UCSF Makes Lemonade, Receives $1.35M for Pediatric Bioresearch

Posted by Robert Larkin on Tue, Jan 20, 2015

When life gives you lemons, make lemonade… and if you’ve got lemonade, make a lemonade stand. However, when Alex’s Lemonade Stand Foundation gives you millions in research funding, now you can help cure childhood cancer. Thanks to a little girl who once made lemonade to raise money for childhood cancer research, two UC San Francisco faculty members are among researchers being nationally acknowledged for their work in pediatric oncology.

Read More

Tags: CA, Bioresearch funding, Leukemia, California, Pediatric Cancer Research, grants, 2015, Biotechnology, Life Science, UCSF, San Francisco at Mission Bay, cancer research funding, Biotechnology Vendor Showcase Event

Rockefeller University Researcher Awarded $1M Grant

Posted by Jennifer Nieuwkerk on Fri, Aug 09, 2013

Science researcher C. David Allis is head of the Laboratory of Chromatin Biology and Epigenetics at Rockefeller University, and he has been awarded a $1 million grant from the Starr Cancer Consortium. As the leader of one of five cancer research teams from New York City based members of the consortium, Allis was one of 27 people to submit a grant application and a member of one of five collaborative cancer research teams selected as a winner. The Starr Cancer Consortium gave out a total of $5 million dollars over two years.

Read More

Tags: Rockefeller University, New York, Northeast, NY, BioResearch Product Faire Event, 2013, cancer research funding, cancer research grant, 2014, RockU

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News